VIRAL PERSISTENCE: GENETIC AND IMMUNOLOGICAL STUDIES
VIRAL PERSISTENCE: GENETIC AND IMMUNOLOGICAL STUDIES
批准号:
3402646
负责人:
Rafi Ahmed
金额:
$12.35万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-05-01 至 1988-04-30
中文摘要
病毒持续存在的机制仍然是一个重大的悬而未决的问题
病毒学。这些研究的长期目标是理解
病毒逃避或抑制免疫反应并持续存在的机制
在宿主中。持续的病毒感染具有重大的医学意义,因为
它们通常会对免疫抑制的个体产生严重的后果,而且
也与肿瘤和免疫病理疾病有关。
小鼠感染淋巴细胞性脉络膜脑膜炎病毒(LCMV)可提供
一种研究病毒与病毒相互作用的极佳模型
它的自然宿主的免疫系统,并在定义导致
病毒清除或持续。拟议研究的目标
是三重的。首先,分析野生动物之间的遗传差异
键入LCMV和LCMV变种,并绘制允许
抑制细胞毒性T细胞(CTL)反应并导致持续性的变体
成年免疫能力强的小鼠的感染。第二,确定角色定位
独特器官特异性病毒选择中的宿主器官和细胞类型
变种。第三,检测变异体与T细胞的相互作用
和巨噬细胞,以阐明CTL抑制的机制。这些
结合病毒学和免疫学学科的研究应该
洞察病毒持续存在的遗传基础。
英文摘要
The mechanism of viral persistence remains a major unresolved problem in
virology. The long-term goal of these studies is to understand the
mechanisms by which virus evade or suppress the immune response and persist
in the host. Persistent viral infections are medically significant because
they often have severe consequences in immunosuppressed individuals, and
have also been associated with neoplasms and immunopathological diseases.
Infection of mice with lymphocytic choriomeningitis virus (LCMV) provides
an excellent model for studying the interaction between the virus and the
immune system of it's natural host, and in defining conditions that lead to
viral clearance or persistence. The objectives of the proposed research
are three-fold. First, to analyze the genetic differences between wild
type LCMV and LCMV variants, and to map the viral genes that allow the
variants to suppress cytotoxic T cell (CTL) responses and cause persistent
infections in adult immunocompetent mice. Second, to determine the role of
host organs and cell types in selection of unique organ specific virus
variants. Third, to examine the interaction of the variants with T cells
and macrophages to elucidate the mechanism of CTL suppression. These
studies, combining the disciplines of virology and immunology, should
provide insight into the genetic basis of viral persistence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunological Memory to Covid-19
-
批准号:10632659
-
项目类别:
-
资助金额:$210.0万
-
财政年份:2022
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10345981
-
项目类别:
-
资助金额:$46.64万
-
财政年份:2021
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10375723
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2021
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Adaptive Responses to vaccination
-
批准号:10201503
-
项目类别:
-
资助金额:$230.01万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10174887
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10056675
-
项目类别:
-
资助金额:$240.49万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10408747
-
项目类别:
-
资助金额:$62.39万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Core-002
-
批准号:10394367
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10524207
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10394365
-
项目类别:
-
资助金额:$251.68万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10201491
-
项目类别:
-
资助金额:$221.36万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Vaccine Induced Immunity in the Young and Aged
-
批准号:10265788
-
项目类别:
-
资助金额:$278.21万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10634636
-
项目类别:
-
资助金额:$61.64万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10381102
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10167989
-
项目类别:
-
资助金额:$219.36万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Core-002
-
批准号:10618504
-
项目类别:
-
资助金额:$3.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10737760
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10618505
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Bispecific molecules linking T cell receptor and tumor antigen for cancer immunotherapy
-
批准号:10747580
-
项目类别:
-
资助金额:$7.99万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
-
批准号:10459440
-
项目类别:
-
资助金额:$53.73万
-
财政年份:2019
-
负责人:Rafi Ahmed
-
依托单位:
海外基金